Literature DB >> 26566609

The early identification of psychosis: can lessons be learnt from cardiac stress testing?

Swapnil Gupta1,2,3, Mohini Ranganathan1,2,3, Deepak Cyril D'Souza4,5,6.   

Abstract

Psychotic disorders including schizophrenia are amongst the most debilitating psychiatric disorders. There is an urgent need to develop methods to identify individuals at risk with greater precision and as early as possible. At present, a prerequisite for a diagnosis of schizophrenia is the occurrence of a psychotic episode. Therefore, attempting to detect schizophrenia on the basis of psychosis is analogous to diagnosing coronary artery disease (CAD) after the occurrence of a myocardial infarction (MI). The introduction of cardiac stress testing (CST) has revolutionized the detection of CAD and the prevention and management of angina and MI. In this paper, we attempt to apply lessons learnt from CST to the early detection of psychosis by proposing the development of an analogous psychosis stress test. We discuss in detail the various parameters of a proposed psychosis stress test including the choice of a suitable psychological or psychopharmacological "stressor," target population, outcome measures, safety of the approach, and the necessary evolution of test to become clinically informative. The history of evolution of CST may guide the development of a similar approach for the detection and management of psychotic disorders. The initial development of a test to unmask latent risk for schizophrenia will require the selection of a suitable and safe stimulus and the development of outcome measures as a prelude to testing in populations with a range of risk to determine predictive value. The use of CST in CAD offers the intriguing possibility that a similar approach may be applied to the detection and management of schizophrenia.

Entities:  

Keywords:  Coronary artery disease; Diagnosis; Psychosis; Risk; Schizophrenia

Mesh:

Year:  2015        PMID: 26566609      PMCID: PMC4703558          DOI: 10.1007/s00213-015-4143-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  132 in total

1.  The schizophrenia ketamine challenge study debate.

Authors:  W T Carpenter
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

2.  A multivariate prediction model of schizophrenia.

Authors:  John W Carter; Fini Schulsinger; Josef Parnas; Tyrone Cannon; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

3.  Maximal treadmill exercise electrocardiography. Correlations with coronary arteriography and cardiac hemodynamics.

Authors:  C M Martin; D R McConahay
Journal:  Circulation       Date:  1972-11       Impact factor: 29.690

4.  Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests.

Authors:  P Rochmis; H Blackburn
Journal:  JAMA       Date:  1971-08-23       Impact factor: 56.272

5.  Postexercise electrocardiogram in arteriosclerotic heart disease. Its value in diagnosis and prognosis.

Authors:  G P Robb; H H Marks
Journal:  JAMA       Date:  1967-06-12       Impact factor: 56.272

6.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

7.  The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.

Authors:  Michelle Carbuto; R Andrew Sewell; Ashley Williams; Kim Forselius-Bielen; Gabriel Braley; Jacqueline Elander; Brian Pittman; Ashley Schnakenberg; Savita Bhakta; Edward Perry; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2011-08-16       Impact factor: 4.530

8.  Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

Authors:  M Davidson; A Reichenberg; J Rabinowitz; M Weiser; Z Kaplan; M Mark
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

9.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

10.  Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.

Authors:  H Verdoux; C Gindre; F Sorbara; M Tournier; J D Swendsen
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723

View more
  1 in total

1.  Assessing the Relationship between Sense of Agency, the Bodily-Self and Stress: Four Virtual-Reality Experiments in Healthy Individuals.

Authors:  Yonatan Stern; Danny Koren; Renana Moebus; Gabriella Panishev; Roy Salomon
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.